The recent instance of pharmaceutical cargo tampering in Thane, Maharashtra, highlights the difficulties that companies encounter in preserving the security and integrity of their supply chains. The pharmaceutical sector is affected significantly by this incidence, which involves the theft and substitution of Gliclazide IP powder valued at over Rs 36 lakh. It also emphasizes the necessity of strict precautions to prevent such incidents.
A 62-year-old businessman from Palghar district submitted the complaint, which claims that unknown people stole Gliclazide IP powder from 20 barrels during transit or storage in a warehouse in Bhiwandi tehsil and replaced it with a material that looked similar. Concerns over the legitimacy and caliber of pharmaceutical raw materials, as well as possible threats to public health and safety, have been raised by this act of tampering.
The Indian Penal Code’s (IPC) sections 406 and 407 are the basis for the filed complaint, which highlights the legal ramifications of criminal breach of trust. The Thane district police are leading the inquiry, which is looking at a number of possibilities, including the possibility that anyone who worked for the transport service or visited the warehouse where the material was kept was involved.
The timing of the tampering, which took place last year between September and November, emphasizes the necessity of improved supply chain and logistical security procedures and monitoring. The monetary damage brought about by the theft highlights the significance of protecting precious assets and the effect it has on organizations.
It is critical to find the perpetrators and fix the security and governance flaws that let this incident happen as the investigation moves forward. To avoid such accidents and maintain the integrity of the pharmaceutical supply chain, businesses, law enforcement agencies, and regulatory bodies must work together. Furthermore, precautions including tighter protocol adherence, increased surveillance, and frequent audits can assist reduce hazards and guarantee the security and legitimacy of pharmaceutical items.
SOURCE:
THE INDIAN COMMUNITY
